FACULTY:
, is a pediatric hematology-oncology specialist in San Antonio, TX and has been practicing for 29 years. She shares her journey from a research-focused career to becoming a clinical expert inspired by the bravery of the children she encountered.
OVERVIEW:
Childhood leukemia is in the news. According to CNN, 15-year-old Carlo Acutis will become the Catholic Church's first millennial saint. He passed away from leukemia in 2006. Leukemia is the most common form of childhood cancer, and 80% of children will survive cancer today. That's what we're talking about here on Pediatrics Now today; the crucial role pediatric practitioners play in caring for patients who are cancer survivors.
OVERALL LEARNING OBJECTIVE:
Increase awareness and education for pediatric providers
DISCLOSURE TO LEARNERS:
, has no financial relationships with ineligible companies to disclose.
The Pediatric Grand Rounds Planning Committee (Deepak Kamat, MD, PhD, Steven Seidner, MD, Daniel Ranch, MD and Elizabeth Hanson, MD) has no financial relationships with ineligible companies to disclose.
The UT Health Science Center San Antonio and Deepak Kamat, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
CONTINUING MEDICAL EDUCATION STATEMENTS:
The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The UT Health Science Center San Antonio designates this live activity up to a maximum of 1.00 AMA PRA Category 1 Creditsâ„¢.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
RELEASE DATE:
7/8/2024
EXPIRATION DATE:
8/31/2026